Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Glox Therapeutics Logo
    21 January 2025

    Glox Therapeutics awarded share of £3M Collaborative Discovery Programme Funding from Cystic Fibrosis Antimicrobial Resistance Syndicate

    £500K grant to advance discovery and development of effective precision antibiotics targeting antimicrobial-resistant lung infections in people with cystic fibrosisProgramme delivered by CF AMR Syndicate offers cross-sector collaboration and support to address urgent unmet needGlasgow, ...

    Sable&Hawkes are a design and communications company that works across print, digital, advertising and social media.
    21 January 2025

    Engineering biology to accelerate breakthroughs in human health

    Sable&Hawkes have been appointed to work with DNA Script on a new set of customer-orientated messages and branded marketing and communications assets. ...

    Lee Patterson, CEO, Metrion Biosciences
    20 January 2025

    Metrion Biosciences listed in The Sunday Times 100 Tech, as one of Britain's fastest-growing private technology companies

    Inaugural feature recognises companies within the UK technology sector, developing or selling a proprietary technology Listing is recognition of Metrion’s leadership position in preclinical ion channel drug discovery research servicesCambridge, UK, 20 January 2025: Metrion Bio...

    logo
    6 January 2025

    Partnership with Cognidox Ltd

    So thrilled to announce this collaboration with Cognidox as part of our joint mission to ensure that business Quality and Systems are running efficiently, along with providing support to easy introduction to ISO certification.  Quote from Cognidox ...

    Milner Consortium Call 2025 - Applications open 7 January 2025, Closing date 7 March 2025
    16 January 2025

    Milner Therapeutics Institute announces 2025 Consortium Call

    The 2025 Milner Therapeutics Consortium Call opened on 13 January, with an exciting new focus around pharma-led challenges. ...

    Luminita.jpg
    15 January 2025

    Salus Wellness Clinics are excited to welcome Luminita Andreescu to the team

    Luminita is a highly qualified acupuncturist with over 40 years of experience as a Registered Nurse and nearly 30 years as a Usui Reiki Master. ...

    Billy Boyle, co-founder and CEO, Owlstone Medical
    15 January 2025

    Owlstone Medical announces $27 Million USD first close in Series E financing round

    Led by Ventura Capital and joined by other investors including Aviva Ventures, the Gates Foundation and Horizons Ventures Funding will be used to accelerate commercialization and further clinical trials of Breath Biopsy diagnostic tests and point of care devices for lung cancer, li...

    Bio-Rad Nuvia wPrime 2A Media
    14 January 2025

    Bio-Rad launches Nuvia wPrime 2A media for biomolecule purification

    Scalable Weak Anion Exchange and Hydrophobic Interaction (AEX-HIC) Mixed-Mode Chromatography Resin Enables Small- to Large-Scale Purification for Research and Biotherapeutic Applications ...

    Sapio Sciences
    14 January 2025

    Sapio Sciences announces enhanced capabilities for chemistry, immunogenicity, GMP and molecular biology

    Sapio Lab Informatics Platform (Release 24.12) further optimizes productivity across lab workflows ...

    Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific
    14 January 2025

    Terumo Blood and Cell Technologies and FUJIFILM Irvine Scientific Collaborate to Accelerate T Cell Expansion for Cell Therapy Developers

    Turnkey solution helps simplify and scale T cell expansion using Fujifilm's PRIME-XV® T Cell Expansion Media on Terumo BCT’s Quantum Flex™ Cell Expansion System, easing the burden for developers ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 102
    • Page 103
    • Current page 104
    • Page 105
    • Page 106
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS